- Home
- KXIN vs PSTV Comparison
KXIN vs PSTV Comparison
Compare KXIN & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KXIN
- PSTV
- Stock Information
- Founded
- KXIN 2015
- PSTV 1996
- Country
- KXIN China
- PSTV United States
- Employees
- KXIN N/A
- PSTV N/A
- Industry
- KXIN Retail-Auto Dealers and Gas Stations
- PSTV Medical/Dental Instruments
- Sector
- KXIN Consumer Discretionary
- PSTV Health Care
- Exchange
- KXIN Nasdaq
- PSTV Nasdaq
- Market Cap
- KXIN 10.5M
- PSTV 9.4M
- IPO Year
- KXIN N/A
- PSTV N/A
- Fundamental
- Price
- KXIN $0.16
- PSTV $1.41
- Analyst Decision
- KXIN
- PSTV Strong Buy
- Analyst Count
- KXIN 0
- PSTV 2
- Target Price
- KXIN N/A
- PSTV $14.00
- AVG Volume (30 Days)
- KXIN 90.2M
- PSTV 84.6K
- Earning Date
- KXIN 01-01-0001
- PSTV 10-29-2024
- Dividend Yield
- KXIN N/A
- PSTV N/A
- EPS Growth
- KXIN N/A
- PSTV N/A
- EPS
- KXIN N/A
- PSTV N/A
- Revenue
- KXIN $12,679,000.00
- PSTV $5,509,000.00
- Revenue This Year
- KXIN N/A
- PSTV $11.13
- Revenue Next Year
- KXIN N/A
- PSTV N/A
- P/E Ratio
- KXIN N/A
- PSTV N/A
- Revenue Growth
- KXIN N/A
- PSTV 113.20
- 52 Week Low
- KXIN $0.06
- PSTV $0.97
- 52 Week High
- KXIN $3.55
- PSTV $2.78
- Technical
- Relative Strength Index (RSI)
- KXIN 49.05
- PSTV 46.79
- Support Level
- KXIN $0.16
- PSTV $1.20
- Resistance Level
- KXIN $0.19
- PSTV $1.45
- Average True Range (ATR)
- KXIN 0.07
- PSTV 0.10
- MACD
- KXIN -0.01
- PSTV 0.01
- Stochastic Oscillator
- KXIN 4.65
- PSTV 57.37
About KXIN Kaixin Auto Holdings
Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company primarily generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).